Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pembrolizumab associated hemophagocytic lymphohistiocytosis.

× No keyword cloud information.

14 in total

Review 1. Hemophagocytic lymphohistiocytosis with immunotherapy: brief review and case report.

Authors: Masood Sadaat; Sekwon Jang
Journal: J Immunother Cancer Date: 2018-06-05 Impact factor: 13.751

2. Hemophagocytic Lymphohistiocytosis in a Patient with Rheumatoid Arthritis on Pembrolizumab for Lung Adenocarcinoma.

Authors: Yu Akagi; Nobuyasu Awano; Minoru Inomata; Naoyuki Kuse; Mari Tone; Hanako Yoshimura; Tatsunori Jo; Kohei Takada; Toshio Kumasaka; Takehiro Izumo
Journal: Intern Med Date: 2020-02-01 Impact factor: 1.271

3. Severe cytokine release syndrome resulting in purpura fulminans despite successful response to nivolumab therapy in a patient with pleomorphic carcinoma of the lung: a case report.

Authors: Osamu Honjo; Terufumi Kubo; Fumiko Sugaya; Takahiro Nishizaka; Koji Kato; Yoshihiko Hirohashi; Hiroki Takahashi; Toshihiko Torigoe
Journal: J Immunother Cancer Date: 2019-04-03 Impact factor: 13.751

4. Hematologic Complications of Immune Checkpoint Inhibitors.

Authors: Elizabeth J Davis; Joe-Elie Salem; Arissa Young; Jennifer R Green; P Brent Ferrell; Kristin K Ancell; Benedicte Lebrun-Vignes; Javid J Moslehi; Douglas B Johnson
Journal: Oncologist Date: 2019-02-28

5. Haemophagocytic lymphohistiocytosis in patients treated with immune checkpoint inhibitors: analysis of WHO global database of individual case safety reports.

Authors: Roberta Noseda; Raffaela Bertoli; Laura Müller; Alessandro Ceschi
Journal: J Immunother Cancer Date: 2019-05-02 Impact factor: 13.751

6. Pembrolizumab-induced Hemophagocytic Lymphohistiocytosis: an immunotherapeutic challenge.

Authors: James Kalmuk; Jon Puchalla; Gong Feng; Anshu Giri; John Kaczmar
Journal: Cancers Head Neck Date: 2020-02-03

7. Clinical diagnosis and treatment recommendations for immune checkpoint inhibitor-related hematological adverse events.

Authors: Junling Zhuang; Jianhua Du; Xiaoxiao Guo; Jiaxin Zhou; Lian Duan; Wei Qiu; Xiaoyan Si; Li Zhang; Yue Li; Xiaowei Liu; Hanping Wang; Daobin Zhou; Li Zhang
Journal: Thorac Cancer Date: 2020-02-03 Impact factor: 3.500

8. Phase I Clinical Trial of Combination Propranolol and Pembrolizumab in Locally Advanced and Metastatic Melanoma: Safety, Tolerability, and Preliminary Evidence of Antitumor Activity.

Authors: Shipra Gandhi; Manu R Pandey; Elizabeth A Repasky; Marc S Ernstoff; Kristopher Attwood; Wenyan Ji; Agnieszka K Witkiewicz; Erik S Knudsen; Cheryl Allen; Joseph D Tario; Paul K Wallace; Carlos D Cedeno; Maria Levis; Suzanne Stack; Pauline Funchain; Joseph J Drabick; Mark J Bucsek; Igor Puzanov; Hemn Mohammadpour
Journal: Clin Cancer Res Date: 2020-10-30 Impact factor: 13.801

9. A case of pembrolizumab-induced hemophagocytic lymphohistiocytosis successfully treated with pulse glucocorticoid therapy.

Authors: Hidenori Takahashi; Tomohiro Koiwa; Akira Fujita; Takayuki Suzuki; Amane Tagashira; Yoshinobu Iwasaki
Journal: Respir Med Case Rep Date: 2020-05-19

Review 10. [Clinical Diagnosis and Treatment Recommendations for Immune Checkpoint Inhibitor-related Hematological Adverse Events].

Authors: Junling Zhuang; Jingting Zhao; Xiaoxiao Guo; Jiaxin Zhou; Lian Duan; Wei Qiu; Xiaoyan Si; Li Zhang; Yue Li; Xiaowei Liu; Hanping Wang; Daobin Zhou; Li Zhang
Journal: Zhongguo Fei Ai Za Zhi Date: 2019-10-20